BRAINSTORM CELL THERAPEUTICS INC. Increase (Decrease) in Restricted Cash
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Increase (Decrease) in Restricted Cash of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2014-05-13
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2014-03-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2013-12-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2013-09-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2013-06-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2013 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2012 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2011 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 129 month | Increase (Decrease) in Restricted Cash 132 month | Increase (Decrease) in Restricted Cash 135 month | Increase (Decrease) in Restricted Cash 138 month | Increase (Decrease) in Restricted Cash 141 month | Increase (Decrease) in Restricted Cash 144 month | Increase (Decrease) in Restricted Cash 147 month | Increase (Decrease) in Restricted Cash 150 month | Increase (Decrease) in Restricted Cash 153 month | Increase (Decrease) in Restricted Cash 156 month | Increase (Decrease) in Restricted Cash 159 month | Increase (Decrease) in Restricted Cash 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | -$6.00K 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | -$6.00K 10-K · filed 2014-03-27 | |||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | -$6.00K 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | -$6.00K 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | -$6.00K 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | -$6.00K 10-K · filed 2013-03-14 | |||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | -$6.00K 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $0.00 derived: sum of 4 quarters · filed 2013-08-14 | -$6.00K 10-Q/A · filed 2012-08-29 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | -$6.00K 10-Q · filed 2012-05-11 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $0.00 derived: sum of 2 quarters · filed 2013-03-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-14 | $0.00 10-K · filed 2013-03-14 | -$6.00K 10-K · filed 2012-03-15 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2012-11-13 | -$6.00K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $0.00 10-Q/A · filed 2012-08-29 | $0.00 derived: sum of 3 quarters · filed 2012-08-29 | $0.00 derived: sum of 4 quarters · filed 2012-08-29 | -$6.00K 10-Q/A · filed 2011-09-07 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-11 | $0.00 derived: sum of 2 quarters · filed 2012-05-11 | $0.00 derived: sum of 3 quarters · filed 2012-05-11 | |||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-K · filed 2012-03-15 | |||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |